Q3 2020 Holdings
Filed 2020-11-16 | 75 holdings | $536.2M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2020-11-17) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $33.8K | 2,287,782 | 0.0% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $36.2K | 975,000 | 0.0% |
| Compugen LTD(CGEN) | ORD | M25722105 | $38.7K | 2,383,673 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $47.3K | 1,354,392 | 0.0% |
| Intercept Pharmaceuticals in(ICPTUSD) | COM | 45845P108 | $48.8K | 1,176,000 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $53.3K | 1,251,959 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $55.0K | 675,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $66.9K | 1,094,000 | 0.0% |
| Odonate Therapeutics Inc | COM | 676079106 | $69.9K | 5,207,086 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $78.3K | 400,000 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $80.5K | 2,268,236 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $99.0K | 2,075,905 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $107.2K | 4,345,016 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $115.2K | 3,309,264 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $293.2K | 1,765,560 | 0.1% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $382.6K | 4,500,000 | 0.1% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $7.1M | 300,000 | 1.3% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $14.8M | 1,000,000 | 2.8% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $15.3M | 370,000 | 2.8% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $17.0M | 1,566,361 | 3.2% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $19.0M | 250,000 | 3.5% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $35.7M | 2,084,883 | 6.7% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $44.9M | 170,926 | 8.4% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $60.9M | 2,014,858 | 11.4% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $319.1M | 1,114,188 | 59.5% |